CEIV 2.0

Project purpose

Following the first project (CEIV 1.0), Pharma.Aero plans to initiate a follow-up project (CEIV 2.0) to evaluate how CEIV Pharma certified companies perceive the impact of being CEIV certified on their daily business and the value that the certification has brought. Furthermore, Pharma.Aero wants to involve their strategic pharma shipper members in evaluating the current CEIV Pharma programme and its impact on their air supply chain requirements.

Project objective(s)

The aim is to obtain the latest industry sentiments on CEIV Pharma and be able to share the recommendations with IATA for them to raise awareness of the programme, engage shippers of the value of CEIV which should aid them in lane assessment, reduction in audit frequency and complexities.

Project status and key-takeaways

Project ongoing, following the steps:

  • Work Package 1: Develop 2 questionnaires (pharma shippers/non-pharma shippers) and implement the survey
  • Work Package 2: Analyse the survey results and create a report
  • Work Package 3: Present and discuss report with IATA, organize and lead problem-solving sessions with IATA and Pharma.Aero members: identify problems, root causes and potential solutions, prioritize problems and define action plan
  • Work Package 4: create final reports (technical report and white paper) and share with our members/partners and the industry

Project support and collaboration

  • Pharma.Aero Board liaison: Brussels Airport Company and Changi Airport Group
  • Project leads: Dnata and FirstPriorityCargo
  • Project members: 38 members respondents to the survey (WP1), Pharma.Aero members and partners involved in the problem-solving sessions organized in collaboration with IATA (WP3)
  • Project expert (WP1): Aynur Rasulova-Rzepa, Rzepa Consulting Limited (external consultant)

Interested? See all of our Projects
My cart
Your cart is empty.

Looks like you haven't made a choice yet.